Latest news with #Drugzone

Time Business News

Pharma Distributors and the Challenge of Counterfeit Drugs: Prevention and Solutions

Counterfeit drugs have become a grave concern in the pharmaceutical industry. They pose severe risks to patient safety and can undermine the trust in healthcare systems. Combating counterfeit drugs is a significant challenge for pharmaceutical wholesalers that require vigilance and advanced strategies. Read on to understand the various complexities associated with counterfeit drugs encountered by pharmaceutical wholesalers. The global nature of drug manufacturing and distribution makes it hard to track every product. Counterfeit drugs can slip into the supply chain at multiple points, which makes them difficult to detect. Oftentimes, pharmaceutical supply chains lack transparency. This opacity can create opportunities for counterfeiters to introduce fake products undetected. Medications in high demand and low supply are prime targets for counterfeiters. Hence, wholesalers need to be extra vigilant with these high-risk drugs. Here's how pharmaceutical wholesalers can prevent the counterfeit drug Implementing digital tracking systems, like blockchain technology, can enhance supply chain transparency. Tracking each drug package from manufacture to delivery can reduce the chances of counterfeits. Using tamper-evident packaging can help identify compromised products. Wholesalers should work with manufacturers to ensure all packaging includes anti-counterfeit measures. Collaborations and Data Sharing Collaborating with other stakeholders in the supply chain, including manufacturers, regulators, and pharmacies, can improve data sharing and collective vigilance against counterfeit drugs. Staying compliant with local and international regulations can help wholesalers monitor and prevent counterfeit drugs. Regular audits and inspections ensure all processes are up to standard. Drugzone, one of the top pharmaceutical distributors in the U.S., strictly follows the rules set by the Drug Supply Chain Security Act (DSCSA). This means they use advanced tracking technologies besides other measures to keep a close eye on every medication they distribute. Counterfeit drugs are fake medications that may contain incorrect or harmful ingredients. They pose serious risks to patient health and safety. TIME BUSINESS NEWS